IL158474A0 - Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation - Google Patents

Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation

Info

Publication number
IL158474A0
IL158474A0 IL15847402A IL15847402A IL158474A0 IL 158474 A0 IL158474 A0 IL 158474A0 IL 15847402 A IL15847402 A IL 15847402A IL 15847402 A IL15847402 A IL 15847402A IL 158474 A0 IL158474 A0 IL 158474A0
Authority
IL
Israel
Prior art keywords
microspheres
coatings
biofunctional
delivery
drug encapsulation
Prior art date
Application number
IL15847402A
Other languages
English (en)
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of IL158474A0 publication Critical patent/IL158474A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A61L27/32—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B40/00—Processes, in general, for influencing or modifying the properties of mortars, concrete or artificial stone compositions, e.g. their setting or hardening ability
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
    • C04B41/009—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone characterised by the material treated
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
    • C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
    • C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
    • C04B41/5076—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials with masses bonded by inorganic cements
    • C04B41/5092—Phosphate cements
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
    • C04B41/60—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone of only artificial stone
    • C04B41/61—Coating or impregnation
    • C04B41/65—Coating or impregnation with inorganic materials
    • C04B41/67—Phosphates
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C30/00—Coating with metallic material characterised only by the composition of the metallic material, i.e. not characterised by the coating process
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ceramic Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Structural Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
IL15847402A 2001-04-20 2002-04-19 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation IL158474A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/838,331 US6730324B2 (en) 2001-04-20 2001-04-20 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
PCT/CA2002/000565 WO2002085330A1 (en) 2001-04-20 2002-04-19 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation

Publications (1)

Publication Number Publication Date
IL158474A0 true IL158474A0 (en) 2004-05-12

Family

ID=25276830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15847402A IL158474A0 (en) 2001-04-20 2002-04-19 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation

Country Status (11)

Country Link
US (1) US6730324B2 (pt)
EP (1) EP1383481B1 (pt)
JP (1) JP4309660B2 (pt)
CN (1) CN1276748C (pt)
AT (1) ATE278393T1 (pt)
BR (1) BR0209040A (pt)
CA (1) CA2444561C (pt)
DE (1) DE60201528T2 (pt)
IL (1) IL158474A0 (pt)
WO (1) WO2002085330A1 (pt)
ZA (1) ZA200308332B (pt)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563874B2 (en) * 1998-08-31 2009-07-21 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US7163541B2 (en) * 2002-12-03 2007-01-16 Arthrosurface Incorporated Tibial resurfacing system
US6610067B2 (en) 2000-05-01 2003-08-26 Arthrosurface, Incorporated System and method for joint resurface repair
EP2314257B9 (en) 2000-05-01 2013-02-27 ArthroSurface, Inc. System for joint resurface repair
US7678151B2 (en) * 2000-05-01 2010-03-16 Ek Steven W System and method for joint resurface repair
US8177841B2 (en) 2000-05-01 2012-05-15 Arthrosurface Inc. System and method for joint resurface repair
US7013182B1 (en) * 2000-05-04 2006-03-14 Cardiac Pacemakers, Inc. Conductive polymer sheath on defibrillator shocking coils
US20030134811A1 (en) * 2001-10-09 2003-07-17 John Jackson Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents
EP1551470A2 (en) * 2002-09-13 2005-07-13 The University of British Columbia Calcium phosphate coated implantable medical devices and processes for making same
SE0203224D0 (sv) * 2002-10-31 2002-10-31 Cerbio Tech Ab Method of making structured ceramic coatings and coated devices prepared with the method
SE525236C2 (sv) * 2002-10-31 2005-01-11 Cerbio Tech Ab Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande
US7901408B2 (en) 2002-12-03 2011-03-08 Arthrosurface, Inc. System and method for retrograde procedure
US7914545B2 (en) 2002-12-03 2011-03-29 Arthrosurface, Inc System and method for retrograde procedure
FR2849436B1 (fr) * 2002-12-27 2007-01-05 Patrick Frayssinet Particules et ceramiques de phosphates de calcium pour transfection in vivo et in vitro
US8388624B2 (en) 2003-02-24 2013-03-05 Arthrosurface Incorporated Trochlear resurfacing system and method
AU2007229327B2 (en) * 2003-03-13 2010-02-11 Nanotrend Ino-Tech Inc. Stable and taste masked pharmaceutical dosage form using porous apatite grains
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
JP4215595B2 (ja) * 2003-08-21 2009-01-28 安正 赤川 インプラント固定部材およびインプラント複合材
WO2005051231A2 (en) 2003-11-20 2005-06-09 Arthrosurface, Inc. Retrograde delivery of resurfacing devices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
SE527610C2 (sv) * 2004-06-15 2006-04-25 Promimic Ab Förfarande för framställning av syntetiskt, kristallint kalciumfosfat i nanostorlek
JP2008504107A (ja) 2004-06-28 2008-02-14 アースロサーフィス・インコーポレーテッド 関節面交換用システム
JP2006034200A (ja) * 2004-07-28 2006-02-09 Pentax Corp 細胞培養担体、細胞培養担体の製造方法および細胞培養方法
US8119153B2 (en) * 2004-08-26 2012-02-21 Boston Scientific Scimed, Inc. Stents with drug eluting coatings
EP1791496B1 (en) 2004-08-31 2019-07-31 C.R. Bard, Inc. Self-sealing ptfe graft with kink resistance
US20060045822A1 (en) * 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
US7828853B2 (en) 2004-11-22 2010-11-09 Arthrosurface, Inc. Articular surface implant and delivery system
US20060199876A1 (en) * 2005-03-04 2006-09-07 The University Of British Columbia Bioceramic composite coatings and process for making same
US8535722B2 (en) * 2005-03-16 2013-09-17 North Carolina State University Functionally graded biocompatible coating and coated implant
US8491936B2 (en) * 2005-03-16 2013-07-23 North Carolina State University Functionally graded biocompatible coating and coated implant
WO2006099748A1 (en) 2005-03-25 2006-09-28 Innovative Bioceramix, Inc. Hydraulic cement compositions and methods of making and using the same
US20060216327A1 (en) * 2005-03-28 2006-09-28 Bacterin, Inc. Multilayer coating for releasing biologically-active agents and method of making
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
US20060257492A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
JP2008543376A (ja) * 2005-06-08 2008-12-04 シー・アール・バード・インコーポレーテッド 無機生体適合性カルシウム塩を有するグラフト及びステント
WO2007001472A2 (en) 2005-06-17 2007-01-04 C. R. Bard, Inc. Vascular graft with kink resistance after clamping
JP5118042B2 (ja) * 2005-09-06 2013-01-16 シー・アール・バード・インコーポレーテッド 薬物結晶を含有する移植用インプラント
US20070051531A1 (en) * 2005-09-08 2007-03-08 Harshad Borgaonkar Drug eluting coatings for a medical lead and method therefor
US8636794B2 (en) 2005-11-09 2014-01-28 C. R. Bard, Inc. Grafts and stent grafts having a radiopaque marker
US8287914B2 (en) 2006-01-12 2012-10-16 Rutgers, The State University Of New Jersey Biomimetic hydroxyapatite synthesis
US20100040668A1 (en) * 2006-01-12 2010-02-18 Rutgers, The State University Of New Jersey Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
US20070207266A1 (en) * 2006-02-15 2007-09-06 Lemke Harald K Method and apparatus for coating particulates utilizing physical vapor deposition
CA2644429C (en) * 2006-03-14 2014-07-29 Lidds Ab Bioresorbable controlled-release composition
US7881808B2 (en) * 2006-03-29 2011-02-01 Cardiac Pacemakers, Inc. Conductive polymeric coating with optional biobeneficial topcoat for a medical lead
US20070282434A1 (en) * 2006-05-30 2007-12-06 Yunbing Wang Copolymer-bioceramic composite implantable medical devices
US7959940B2 (en) 2006-05-30 2011-06-14 Advanced Cardiovascular Systems, Inc. Polymer-bioceramic composite implantable medical devices
EP2079575B1 (en) 2006-10-12 2021-06-02 C.R. Bard, Inc. Methods for making vascular grafts with multiple channels
US10772987B2 (en) 2006-10-30 2020-09-15 Trs Holdings Llc Mineral coated scaffolds
US12171904B2 (en) 2006-10-30 2024-12-24 Trs Holdings Llc Mineral coated scaffolds
WO2010036919A1 (en) * 2008-09-25 2010-04-01 Tissue Regeneration Systems, Inc. Mineral-coated microspheres
US20080119927A1 (en) * 2006-11-17 2008-05-22 Medtronic Vascular, Inc. Stent Coating Including Therapeutic Biodegradable Glass, and Method of Making
AU2007332787A1 (en) 2006-12-11 2008-06-19 Arthrosurface Incorporated Retrograde resection apparatus and method
EP2106217B1 (en) * 2006-12-12 2019-03-13 Firmenich S.A. Active ingredient delivery system with an amorphous metal salt as carrier
WO2009008916A2 (en) 2007-03-22 2009-01-15 The Regents Of The University Of Californina Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
US8753831B2 (en) 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
US8425591B1 (en) 2007-06-11 2013-04-23 Abbott Cardiovascular Systems Inc. Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
KR101165455B1 (ko) * 2007-09-10 2012-07-12 한스바이오메드 주식회사 인산칼슘 마이크로스피어 약물전달체 및 이의 제조방법
US20090076116A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched carvediolo
US8608049B2 (en) 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
WO2009111481A1 (en) 2008-03-03 2009-09-11 Arthrosurface Incorporated Bone resurfacing system and method
EP2262851B1 (en) 2008-03-13 2017-09-27 Board of Regents, The University of Texas System Covalently functionalized particles for synthesis of new composite materials
WO2009132411A1 (en) * 2008-04-28 2009-11-05 The University Of British Columbia Polymer-free drug delivery system for implantable medical devices
WO2010009390A2 (en) * 2008-07-18 2010-01-21 North Carolina State University Processing of biocompatible coating on polymeric implants
CA2732003A1 (en) 2008-07-31 2010-02-04 James D. Marks Antibodies that neutralize botulinum neurotoxins
JP5638003B2 (ja) 2009-01-12 2014-12-10 ユニバーシティ オブ マサチューセッツ ローウェル ポリイソブチレン系ポリウレタン
CN102341105B (zh) 2009-02-03 2014-09-17 微生物公司 用作上皮组织、急性和慢性伤口、细菌生物被膜和其他适应症的抗菌剂的铋硫醇
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
GB2479514A (en) * 2009-02-23 2011-10-12 Arthrosurface Inc Nanorough alloy substrate
US10945743B2 (en) 2009-04-17 2021-03-16 Arthrosurface Incorporated Glenoid repair system and methods of use thereof
WO2010121250A1 (en) 2009-04-17 2010-10-21 Arthrosurface Incorporated Glenoid resurfacing system and method
CA3064646C (en) 2009-04-17 2023-01-03 Arthrosurface Incorporated Glenoid resurfacing system and method
CN102573940B (zh) 2009-08-21 2015-04-01 心脏起搏器公司 可交联聚异丁烯类聚合物及包含其的医疗装置
US8753708B2 (en) * 2009-09-02 2014-06-17 Cardiac Pacemakers, Inc. Solventless method for forming a coating on a medical electrical lead body
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
BR112012022482A2 (pt) 2010-03-05 2016-07-19 Arthrosurface Inc sistema e método de recomposição da superfície tibial.
RU2456253C2 (ru) * 2010-06-24 2012-07-20 Государственное учебно-научное учреждение Факультет Наук о Материалах Московского Государственного Университета им. М.В. Ломоносова Способ подготовки шихты для получения керамического биодеградируемого материала
US9243057B2 (en) 2010-08-31 2016-01-26 The Regents Of The University Of California Antibodies for botulinum neurotoxins
ES2652613T3 (es) * 2010-12-03 2018-02-05 Holcim Technology Ltd. Microcápsula
US9066716B2 (en) 2011-03-30 2015-06-30 Arthrosurface Incorporated Suture coil and suture sheath for tissue repair
EP2804565B1 (en) 2011-12-22 2018-03-07 Arthrosurface Incorporated System for bone fixation
DE112013003358T5 (de) 2012-07-03 2015-03-19 Arthrosurface, Inc. System und Verfahren für Gelenkoberflächenersatz und -reparatur
US9926399B2 (en) 2012-11-21 2018-03-27 University Of Massachusetts High strength polyisobutylene polyurethanes
US9492200B2 (en) 2013-04-16 2016-11-15 Arthrosurface Incorporated Suture system and method
US9931219B2 (en) 2014-03-07 2018-04-03 Arthrosurface Incorporated Implant and anchor assembly
US11607319B2 (en) 2014-03-07 2023-03-21 Arthrosurface Incorporated System and method for repairing articular surfaces
US10624748B2 (en) 2014-03-07 2020-04-21 Arthrosurface Incorporated System and method for repairing articular surfaces
JP6827960B2 (ja) 2015-03-03 2021-02-10 ティーアールエス ホールディングス リミテッド ライアビリティ カンパニー コーティングスキャフォールド
WO2018165273A1 (en) 2017-03-07 2018-09-13 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
CA3108761A1 (en) 2017-08-04 2019-02-07 Arthrosurface Incorporated Multicomponent articular surface implant
US10835638B2 (en) 2017-08-17 2020-11-17 Cardiac Pacemakers, Inc. Photocrosslinked polymers for enhanced durability
US12181452B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709155B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US12180581B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709156B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved analytical analysis
US11472911B2 (en) 2018-01-17 2022-10-18 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane
EP3572102B1 (en) * 2018-05-21 2021-02-24 OssDsign AB Two-paste cement-forming compositions
MX2021001276A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos para tratar heridas.
JP7564101B2 (ja) 2018-07-31 2024-10-08 マイクロビオン コーポレーション ビスマスチオール組成物及び使用方法
GB2609338B (en) 2019-03-12 2023-06-14 Arthrosurface Inc Humeral and glenoid articular surface implant systems and methods
CN112843090A (zh) * 2019-11-28 2021-05-28 华东理工大学 逆转肿瘤耐药性的羟基磷灰石纳米粒子制备方法和应用
US11918936B2 (en) 2020-01-17 2024-03-05 Waters Technologies Corporation Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding
EP4628889A3 (en) 2020-09-24 2025-12-10 Waters Technologies Corporation Chromatographic hardware improvements for the separation of reactive molecules
PL438209A1 (pl) 2021-06-20 2022-12-27 Instytut Wysokich Ciśnień Polskiej Akademii Nauk Hydroksyapatytowa warstwa biobójczo-osteoindukcyjna i sposób wytwarzania takiej warstwy
CN114057173B (zh) * 2021-09-13 2023-12-15 曲阜师范大学 一种利用晶种合成大比表面积羟基磷灰石的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055307A (en) 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
JP2756703B2 (ja) * 1989-06-15 1998-05-25 日本化学工業株式会社 球状アパタイトおよびその製造法並びに多孔質構造成形体
US5525148A (en) 1993-09-24 1996-06-11 American Dental Association Health Foundation Self-setting calcium phosphate cements and methods for preparing and using them
US5496399A (en) * 1994-08-23 1996-03-05 Norian Corporation Storage stable calcium phosphate cements
US5783217A (en) * 1995-11-07 1998-07-21 Etex Corporation Low temperature calcium phosphate apatite and a method of its manufacture
CA2268156C (en) 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
DE69729647T2 (de) 1996-10-16 2005-07-07 Etex Corp., Cambridge Verfahren zur Herstellung von wenigkristallinem Calciumphosphat und Verfahren zu dessen Verwendung
CA2285430C (en) * 1997-04-01 2008-11-18 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
US5993535A (en) 1997-08-28 1999-11-30 Ngk Spark Plug Co., Ltd. Calcium phosphate cement and calcium phosphate cement composition
US5958430A (en) 1998-02-20 1999-09-28 Battelle Memorial Institute Thin film composition with biological substance and method of making
DK1123081T3 (da) 1998-10-19 2003-03-24 Synthes Ag Hærdelig keramisk hydraulisk cement

Also Published As

Publication number Publication date
JP2004530675A (ja) 2004-10-07
CN1512876A (zh) 2004-07-14
CN1276748C (zh) 2006-09-27
US6730324B2 (en) 2004-05-04
EP1383481A1 (en) 2004-01-28
CA2444561A1 (en) 2002-10-31
EP1383481B1 (en) 2004-10-06
BR0209040A (pt) 2004-08-10
ZA200308332B (en) 2005-01-21
ATE278393T1 (de) 2004-10-15
US20020155144A1 (en) 2002-10-24
JP4309660B2 (ja) 2009-08-05
DE60201528T2 (de) 2006-02-02
WO2002085330A1 (en) 2002-10-31
DE60201528D1 (de) 2004-11-11
CA2444561C (en) 2008-03-11

Similar Documents

Publication Publication Date Title
CA2444561A1 (en) Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
IL160015A0 (en) Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
IL156780A0 (en) Modular transfection systems
BG106106A (en) Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
PT910647E (pt) Variantes hiperactivas da dnase i humana
HUP0302897A3 (en) Improved transdermal therapeutic system for treatment of parkinson's disese
DK0862416T3 (da) Ikke-polymert indgivelsessystem med forhalet frigørelse
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO1998049300A3 (en) Truncated vegf-related proteins
IL115517A0 (en) Biologically active proteins
SG161307A1 (en) Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
EP1420716A4 (en) IMPLANTABLE AND SEALABLE SYSTEM FOR THE UNIDIRECTIONAL DISTRIBUTION OF THERAPEUTIC AGENTS OF TARGET TISSUE
GB0100551D0 (en) Protein
MX9708854A (es) Terapia de genes para regulacion de celulas efectoras.
ATE465743T1 (de) Oligonucleotide zur behandlung von prostatakrebs und anderen krebserkrankungen
SE0100566D0 (sv) Compounds
WO1998059040A3 (de) Humane katalytische telomerase-untereinheit und deren diagnostische und therapeutische verwendung
DE50010519D1 (de) Pharmazeutische Zusammensetzungen zur Therapie der Herzinsuffizienz
MX351282B (es) Stent de metal sin recubrir con depósitos de elución de fármaco que tiene retención de fármaco mejorada.
MXPA03009528A (es) Terapia genica con oligonucleotidos quimericos suministrados a traves de un metodo que comprende un paso de iontoforesis.
AU2002342048A1 (en) Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer
WO2001024764A3 (en) Cell targeting compositions and methods of using the same
ATE384133T1 (de) Retinolsäure-rezeptor beta-2 und gentherapievektoren für die behandlung von neurologischen erkrankungen